Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?

被引：20
|
作者：
Trifiro, Gianluca [1 ]
Crisafulli, Salvatore [1 ]
Ando, Giuseppe [2 ]
Racagni, Giorgio [3 ]
Drago, Filippo [4 ]
机构：
[1] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy
[2] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[3] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy
[4] Univ Catania, Univ Hosp, Clin Pharmacol Unit, Dept Biomed & Biotechnol Sci, Catania, Italy
来源：
DRUG SAFETY | 2020年 / 43卷 / 06期
关键词：
GUIDELINES; ESC;
D O I：
10.1007/s40264-020-00935-2
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：507 / 509
页数：3
相关论文
共 50 条
  • [1] Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
    Gianluca Trifirò
    Salvatore Crisafulli
    Giuseppe Andò
    Giorgio Racagni
    Filippo Drago
    Drug Safety, 2020, 43 : 507 - 509
  • [2] Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients
    Sriram, Krishna
    Insel, Paul A.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (01) : L37 - L38
  • [3] Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease
    Jennings, Garry L. R.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 212 (11) : 502 - +
  • [4] ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19
    Tetlow, S.
    Segiet-Swiecicka, A.
    O'Sullivan, R.
    O'Halloran, S.
    Kalb, K.
    Brathwaite-Shirley, C.
    Alger, L.
    Ankuli, A.
    Baig, M. S.
    Catmur, F.
    Chan, T.
    Dudley, D.
    Fisher, J.
    Iqbal, M. U.
    Puczynska, J.
    Wilkins, R.
    Bygate, R.
    Roberts, P.
    JOURNAL OF INTERNAL MEDICINE, 2021, 289 (05) : 688 - 699
  • [5] ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19
    Wang, Yueying
    Tse, Gary
    Li, Guangping
    Lip, Gregory Y. H.
    Liu, Tong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : 2041 - 2041
  • [6] A Comparison of Disease Severity and Outcomes in COVID-19 Cases Taking Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Versus Other Antihypertensive Drugs
    Abdullah, Muhammad, Sr.
    Khan, Khurshid
    Javed, Munaza
    Iqbal, Javeid
    Waheed, Khalid
    Akhtar, Muhammad Naeem
    Chachar, Aijaz Zeeshan K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [7] Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
    Sommerstein, Rami
    Kochen, Michael M.
    Messerli, Franz H.
    Graeni, Christoph
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (07):
  • [8] Ace Inhibitors, Angiotensin Receptor Blockers, and Outcomes in Hospitalized Patients With Severe Covid-19 Pneumonia
    Grewal, Prabhjot
    Yoo, Jeanwoo
    Papamanoli, Aikaterini
    Mojahedi, Azad
    Dhaliwal, Simrat
    Nakamura, Jacquelyn
    Abata, Joshua
    Robin, Jacob
    Fung, Jenny
    Hotelling, Jessica
    Rawal, Sahil
    Karkala, Nikitha
    Tsui, Stella T.
    Coritsidis, Alexandra
    Marcos, Luis
    Bloom, Michelle E.
    Skopicki, Hal
    Kalogeropoulos, Andreas P.
    CIRCULATION, 2020, 142
  • [9] Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
    Ci Tian
    Nan Li
    Yi Bai
    Han Xiao
    Shu Li
    Qing-Gang Ge
    Ning Shen
    Qing-Bian Ma
    World Journal of Clinical Cases, 2021, 9 (01) : 47 - 60
  • [10] Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
    Tian, Ci
    Li, Nan
    Bai, Yi
    Xiao, Han
    Li, Shu
    Ge, Qing-Gang
    Shen, Ning
    Ma, Qing-Bian
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (01) : 47 - 60
12345